• 10X, BioNano Publishes De Novo Assembly

    Bio-IT World News Brief  Yesterday, 10x Genomics announced the publication of a study in Nature Methods highlighting the benefits of their GemCode Technology to generate high-quality assemblies of complex genomes with their proprietary Linked-Read approach. The article demonstrates a new strategy for performing rapid, accurate and cost-effective de novo genome assembly using 10x Genomics’ Linked-Reads in combination with technologies from BioNano.

    May 10, 2016

  • Across The Board Ideas To Narrow Biotechs Gender Gap

    Xconomy | The evidence is piling up. Companies with more women in charge are better businesses. So why are so many biotechs still led mainly by men?

    May 10, 2016

  • IBMs Watson is going to cybersecurity school

    Computerworld | The result will be a cloud service called Watson for Cyber Security that's designed to provide insights into emerging threats as well as recommendations on how to stop them.

    May 10, 2016

  • CRISPR Drug Maker Intellia Therapeutics Sells $108M In IPO Shares

    Xconomy | The latest biopharmaceutical company testing Wall Street's belief in the promise of gene modification has gone public. Intellia Therapeutics sold 6 million shares at $18 each to raise $108 million.

    May 6, 2016

  • Gene Therapy’s First Out-and-Out Cure Is Here

    MIT Technology Review | A genetic therapy for "bubble boy" disease completes a 27-year journey.

    May 6, 2016

  • The New Parasite Award Recognizes Secondary Analysis of Data

    STAT | The current incentives structure - mostly based on publishing in prestigious journals - discourages sharing, replication, and, some argue, careful science.

    May 5, 2016

  • Tech groups call on presidential candidates to support encryption embrace other IT issues

    Computerworld | U.S. presidential candidates should embrace encryption and narrow government access to Internet users' data as part of a comprehensive technology agenda, 13 IT trade groups recommended.

    May 5, 2016

  • How Blockchain Is Helping Genomics Research

    Bio-IT World | John Mattison predicts that blockchain, "is going to be the most disruptive technology in this space other than big-data analytics."

    May 4, 2016

  • The World’s Most Expensive Medicine Is a Bust

    MIT Technology Review | The first gene therapy approved in the Western world costs $1 million and has been used just once. The doctor who tried it says the price is "absolutely too high."

    May 4, 2016

  • IBM launches quantum computing for the rest of us

    Mashable | IBM unveiled the world's first cloud-based quantum computing experience. Starting today, anyone can access the quantum computing hardware based at IBM's T.J. Watson Research Center in Yorktown Heights, New York.

    May 4, 2016

  • This MIT employee redefined how universities launch startups

    STAT | Lita Nelsen of the Technology Licensing Office at MIT became an evangelist for tech transfer and a mentor to her counterparts around the world.

    May 3, 2016

  • Genomic Data and Drug Development EMA Offers New Draft Guidance

    RAPS | The European Medicines Agency has released a new draft guidance to provide industry with more insight on how to identify and understand genomic factors that influence drug responses.

    May 2, 2016

  • The Struggle With Image Glut

    Nature News & Comment | Experiments that generate millions of images have forced scientists to find new ways to store and share terabytes of experimental data.

    May 2, 2016

  • Three Pharma Data Challenges and How to Overcome Them

    Bio-IT World | Contributed Commentary | There’s no lack of ideas about what is needed to make advancements in life sciences research and improving patient care: real-time research, humanizing big data, enhancing customer values and motivation, and that’s just for starters. It was evident that these data struggles were on the minds of attendees at the recent Bio-IT World 2016 Conference in Boston.

    Apr 29, 2016

  • AbbVie Buying Cancer Drug Startup Stemcentrx

    Fortune | AbbVie will buy Stemcentrx, which has five drugs targeting "cancer stem cells" in early clinical trials, for up to $10.2 billion in cash and stock.

    Apr 28, 2016

  • Emmanuelle Charpentier, the Quiet Revolutionary

    Nature News | The microbiologist spent years moving labs and relishing solitude. Then her work on gene-editing thrust her into the scientific spotlight.

    Apr 28, 2016

  • April News and Product Briefs

    Bio-IT World | The latest news and product releases from around the industry, including Novogene's new U.S. sequencing center, and a bioinformatics solution for liquid biopsies from QIAGEN.

    Apr 27, 2016

  • JAX and Calico Apply Mouse Genetics to Aging

    Bio-IT World News Brief | The Jackson Laboratory (JAX) and Calico today announced a multi-year collaboration focused on applying mouse genetics to the study of aging.

    Apr 26, 2016

  • U.S. efforts to build next-gen supercomputer take shape

    Computerworld | While early goals had the US achieving exascale computing by 2018, the new deadline is 2023.

    Apr 26, 2016

  • SwiftStack Announces 4.0 Delivering Scale and Metadata Search

    Bio-IT World  | SwiftStack today announced the latest version of its object storage software with new customer-driven capabilities that deliver scale and metadata search as well as plans for file native access and cloud synchronization. These new features are designed to further simplify and accelerate customer journeys from traditional file systems to more flexible, scalable cloud infrastructures.

    Apr 26, 2016